A phase II pilot trial investigating the efficacy and activity of single agent granulocyte macrophage colony-stimulating factor as maintenance approach in castration - resistant prostate cancer patients responding to chemotherapy
Purpose: To investigate the toxicity and efficacy of GM-CSF in castration-resistant prostate cancer (CRPC) patients who maximized their response to systemic chemotherapy. Materials and Methods: CRPC patients who maximized their response to either docetaxel or mitoxantrone chemotherapy were eligible...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/7da2de9150f640a6818140361796f919 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|